Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma
Protocol ID
ANBL1232
Disease (Sub Disease)
Ganglioneuroblastoma
Neuroblastoma
Diagnosis Stage
Relapse/refractory
Location
NSW, QLD, WA, SA, NZ
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Trial Status
Open
Sites
The Children's Hospital at Westmead
John Hunter Children's Hospital
Perth Children's Hospital
Queensland Children's Hospital
Sydney Children's Hospital
Women's & Children's Hospital
Christchurch Hospital
Starship Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
up to 18 months
International registry ID's
NCT02176967
Back to Registry
Study Title Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma
Protocol ID ANBL1232
Disease (Sub Disease) Ganglioneuroblastoma
Neuroblastoma
Diagnosis Stage Relapse/refractory
Location NSW / QLD / WA / SA / NZ
Sponsor Children's Oncology Group
Collaborators National Cancer Institute (NCI)
Links https://clinicaltrials.gov/ct2/show/NCT02176967
Trial Status Open
Trial Open Date 28/07/2014
Sites The Children's Hospital at Westmead / John Hunter Children's Hospital / Perth Children's Hospital / Queensland Children's Hospital / Sydney Children's Hospital / Women's & Children's Hospital / Christchurch Hospital / Starship Hospital
Study Type Treatment
Phase Phase 3
Age Eligibility up to 18 months
International registry ID's NCT02176967